ACELYRIN, INC. to Participate in Upcoming Investor Conferences
ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focusing on immunology, has announced its participation in three upcoming investor conferences in September 2024. The company's management team will engage in fireside chats and one-on-one meetings at the following events:
- Wells Fargo Healthcare Conference in Boston on September 5
- Morgan Stanley 22nd Annual Global Healthcare Conference in New York on September 6
- H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9
Live webcasts of the fireside chats will be available on ACELYRIN's website, with replays accessible for 30 days after each event.
ACELYRIN, INC. (Nasdaq: SLRN), un'azienda biofarmaceutica in fase avanzata focalizzata sull'immunologia, ha annunciato la sua partecipazione a tre prossimi conferenze per investitori nel settembre 2024. Il team di gestione dell'azienda parteciperà a chiacchierate informali e incontri one-to-one durante i seguenti eventi:
- Wells Fargo Healthcare Conference a Boston il 5 settembre
- Morgan Stanley 22nd Annual Global Healthcare Conference a New York il 6 settembre
- H.C. Wainwright 26th Annual Global Investment Conference a New York il 9 settembre
I webcast in diretta delle chiacchierate informali saranno disponibili sul sito web di ACELYRIN, con repliche accessibili per 30 giorni dopo ogni evento.
ACELYRIN, INC. (Nasdaq: SLRN), una empresa biofarmacéutica en etapa avanzada centrada en la inmunología, ha anunciado su participación en tres próximas conferencias para inversores en septiembre de 2024. El equipo de gestión de la empresa participará en conversaciones informales y reuniones uno a uno en los siguientes eventos:
- Wells Fargo Healthcare Conference en Boston el 5 de septiembre
- Morgan Stanley 22nd Annual Global Healthcare Conference en Nueva York el 6 de septiembre
- H.C. Wainwright 26th Annual Global Investment Conference en Nueva York el 9 de septiembre
Las transmisiones en vivo de las conversaciones informales estarán disponibles en el sitio web de ACELYRIN, con repeticiones accesibles durante 30 días después de cada evento.
ACELYRIN, INC. (Nasdaq: SLRN), 면역학에 중점을 둔 후기 단계 임상 생명공학 회사가 2024년 9월에 열리는 세 가지 투자자 회의에 참가할 것이라고 발표했습니다. 회사의 관리 팀은 다음 행사에서 담소 및 일대일 미팅에 참여할 예정입니다:
- Wells Fargo Healthcare Conference 보스턴에서 9월 5일
- Morgan Stanley 22nd Annual Global Healthcare Conference 뉴욕에서 9월 6일
- H.C. Wainwright 26th Annual Global Investment Conference 뉴욕에서 9월 9일
담소의 라이브 웹캐스트는 ACELYRIN의 웹사이트에서 이용 가능하며, 각 행사 후 30일 동안 다시 볼 수 있습니다.
ACELYRIN, INC. (Nasdaq: SLRN), une entreprise biopharmaceutique en phase avancée axée sur l'immunologie, a annoncé sa participation à trois conférences pour investisseurs prévues en septembre 2024. L'équipe de direction de l'entreprise participera à des discussions informelles et à des réunions individuelles lors des événements suivants :
- Wells Fargo Healthcare Conference à Boston le 5 septembre
- Morgan Stanley 22nd Annual Global Healthcare Conference à New York le 6 septembre
- H.C. Wainwright 26th Annual Global Investment Conference à New York le 9 septembre
Des webinaires en direct des discussions informelles seront disponibles sur le site web d'ACELYRIN, avec des replays accessibles pendant 30 jours après chaque événement.
ACELYRIN, INC. (Nasdaq: SLRN), ein biopharmazeutisches Unternehmen in der späten Entwicklungsphase, das sich auf Immunologie spezialisiert hat, gab seine Teilnahme an drei bevorstehenden Investorenkonferenzen im September 2024 bekannt. Das Managementteam des Unternehmens wird an informellen Gesprächen und Einzelgesprächen bei den folgenden Veranstaltungen teilnehmen:
- Wells Fargo Healthcare Conference in Boston am 5. September
- Morgan Stanley 22nd Annual Global Healthcare Conference in New York am 6. September
- H.C. Wainwright 26th Annual Global Investment Conference in New York am 9. September
Live-Webcasts der informellen Gespräche werden auf der Website von ACELYRIN verfügbar sein, mit Aufzeichnungen, die 30 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
LOS ANGELES, Aug. 22, 2024 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in immunology, today announced that members of its management team will participate in fireside chats and 1x1 meetings at the following investor conferences:
Wells Fargo Healthcare Conference 2024
Date: Thursday, September 5, 2024
Location: Boston, MA
Fireside chat: 1:30 PM - 2:05 PM ET
Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Friday, September 6, 2024
Location: New York, NY
Fireside chat: 11:30 AM - 12:05 PM ET
H.C. Wainwright 26th Annual Global Investment Conference
Date: Monday, September 9, 2024
Location: New York, NY
Fireside chat: 2:00 PM - 2:30 PM ET
Live webcasts of the fireside chats will be available on the Company’s website under Events & Presentations. Replays of each webcast will be available on the Company’s website for 30 days following the event.
About ACELYRIN, INC.
ACELYRIN, INC. (Nasdaq: SLRN) is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines. ACELYRIN’s lead program, lonigutamab, is a subcutaneously delivered monoclonal antibody targeting IGF-1R being investigated for the treatment of thyroid eye disease.
For more information about ACELYRIN, visit us at www.acelyrin.com or follow us on LinkedIn and X.
Forward Looking Statements
Some statements in this press release are, or may be considered, forward-looking statements, including statements regarding ACELYRIN’s business plans and potential future benefits of our pipeline. While ACELYRIN, INC. considers any projections to be based on reasonable assumptions, these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those anticipated in such forward-looking statements.
ACELYRIN Contacts:
Tyler Marciniak
Vice President of Investor Relations and Corporate Affairs
investors@acelyrin.com
media@acelyrin.com
FAQ
What investor conferences will ACELYRIN (SLRN) attend in September 2024?
Where can investors watch ACELYRIN's (SLRN) fireside chats from the September 2024 conferences?
What is the focus of ACELYRIN (SLRN) as a biopharma company?
When and where will ACELYRIN (SLRN) participate in the Wells Fargo Healthcare Conference 2024?
